Encouraging NS-065 Top-Line Data, However, Uptravi’s Global Ramp-Up Remains the Key
We reiterate our “Overweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings. Our rating is subject to Uptravi’s...
285 Views
Nippon Shinyaku Stock up 6% Provides Profit Booking Opportunity
Announcement – Nippon Shinyaku Co Ltd (4516 JP), on May 10, 2018, announced that presentations on NS-065/ NCNP-01 will be given at 2018 New...
301 Views
Nippon Shinyaku FY17 Earnings - First Glance
Nippon Shinyaku Co Ltd (4516 JP) reported FY17 results on May 09, 2018 Brisk global uptake of recently launched Uptravi and Zalutia drove FY17...
233 Views
Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas
Takeda Pharmaceutical Co Ltd (4502 JP), Shionogi & Co Ltd (4507 JP), Nippon Shinyaku Co Ltd (4516 JP) , Sumitomo Dainippon Pharma Co (4506 JP),...
316 Views
Japan Pharmaceutical - Sector Overview
Core coverage – relative valuations Takeda Pharmaceutical Co Ltd (4502 JP) (NB: Pre-Shire announcement | Pro-Forma analysis to be published...
329 Views